Inventor · disambiguated record
David C. Tully
Also filed as: TULLY DAVID · TULLY DAVID C · TULLY DAVID CHARLES
27 granted patents·19 pending applications·80 citations·filing 2003–2025
94Inventor score
Top patents by PatentIndex Score
46 records- 0189US9150568B2Compositions and methods for modulating FXRTULLY DAVID C·Filed 2011·Granted Oct 6, 2015·18 cites·29 claims
- 0286US10077240B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2017·Granted Sep 18, 2018·4 cites·15 claims
- 0383US7307095B2Inhibitors of cathepsin SIRM LLC·Filed 2007·Granted Dec 11, 2007·4 cites·18 claims
- 0482US7951823B2Compounds and compositions as channel activating protease inhibitorsIRM LLC·Filed 2007·Granted May 31, 2011·6 cites·15 claims
- 0580US7939547B2Compounds and compositions as channel activating protease inhibitorsIRM LLC·Filed 2007·Granted May 10, 2011·4 cites·17 claims
- 0680US7109243B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Sep 19, 2006·14 cites·19 claims
- 0779US9682939B2Compositions and methods for modulating farnesoid X receptorsCHIANELLI DONATELLA·Filed 2014·Granted Jun 20, 2017·3 cites·27 claims
- 0877US9963454B2Compounds and compositions for the treatment of parasitic diseaseCHATTERJEE ARNAB K·Filed 2015·Granted May 8, 2018·2 cites·13 claims
- 0977US2025353820A1Antiviral pyrazolopyridinone compoundsNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1076US9469645B2Compounds and compositions for the treatment of parasitic diseasesCHATTERJEE ARNAB K·Filed 2013·Granted Oct 18, 2016·3 cites·13 claims
- 1176US6906158B2Compositions and methods of vinyl oxazolone polymerizationIRM LLC·Filed 2004·Granted Jun 14, 2005·15 cites·54 claims
- 1272US10683271B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2018·Granted Jun 16, 2020·0 cites·15 claims
- 1372US8557801B2Compounds and compositions useful for the treatment of parasitic diseasesCHATTERJEE ARNAB K·Filed 2010·Granted Oct 15, 2013·2 cites·10 claims
- 1472US2021253534A1Compositions and methods for modulating farnesoid x receptorsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1571US11021446B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2020·Granted Jun 1, 2021·0 cites·13 claims
- 1670US8293915B2Compounds and compositions as channel activating protease inhibitorsTULLY DAVID C·Filed 2008·Granted Oct 23, 2012·1 cites·12 claims
- 1769US12338220B2Antiviral pyrazolopiridinone compoundsNOVARTIS AG·Filed 2023·Granted Jun 24, 2025·0 cites·21 claims
- 1867US2025066356A1Lrrk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1964US12466821B2Antiviral pyridopyrazinedione compoundsNOVARTIS AG·Filed 2021·Granted Nov 11, 2025·0 cites·10 claims
- 2064US7732449B2Inhibitors of cathepsin SIRM LLC·Filed 2009·Granted Jun 8, 2010·0 cites·16 claims
- 2163US7173051B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Feb 6, 2007·2 cites·24 claims
- 2263US2025270209A1Lrrk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2362US7384970B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Jun 10, 2008·2 cites·15 claims
- 2461US7501408B2Inhibitors of cathepsin SIRM LLC·Filed 2007·Granted Mar 10, 2009·0 cites·16 claims
- 2561US2025346593A1Imidazo(1,2-1)pyridine derivatives as ripk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2660US11667613B2Antiviral pyrazolopyridinone compoundsNOVARTIS AG·Filed 2020·Granted Jun 6, 2023·0 cites·38 claims
- 2759US2008242671A1Inhibitors of cathepsin sIRM LLC·Filed 2008·Application pending·0 cites
- 2857US2024360082A1Substituted pyridone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2956US7314872B2Inhibitors of cathepsin SIRM LLC·Filed 2004·Granted Jan 1, 2008·0 cites·15 claims
- 3055US11072610B2Antiviral pyridopyrazinedione compoundsNOVARTIS AG·Filed 2019·Granted Jul 27, 2021·0 cites·21 claims
- 3150US2010204200A1Inhibitors of cathepsin sIRM LLC·Filed 2010·Application pending·0 cites
- 3249US7985749B2Compounds and compositions as cathepsin S inhibitorsNOVARTIS AG·Filed 2005·Granted Jul 26, 2011·0 cites·9 claims
- 3349US2004009911A1Hepsin substrates and prodrugsIRM LLC·Filed 2003·Application pending·0 cites
- 3447US2010239551A1Compounds and compositions as channel activating protease inhibitorsIRM LLC·Filed 2008·Application pending·0 cites
- 3547US2004141887A1Apparatus and methods to process substrate surface featuresIRM LLC·Filed 2003·Application pending·0 cites
- 3646US8268996B2Compounds and compositions as cathepsin S inhibitorsLIU HONG·Filed 2011·Granted Sep 18, 2012·0 cites·8 claims
- 3746US2008176901A1Compounds and compositions as channel activating protease inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 3845US2011177055A1Compounds and compositions as channel activating protease inhibitorsIRM LLC·Filed 2011·Application pending·0 cites
- 3942US8338469B2Compounds and compositions as channel activating protease inhibitorsTULLY DAVID C·Filed 2011·Granted Dec 25, 2012·0 cites·15 claims
- 4042US2009203777A1Organic compoundsDANAHAY HENRY LUKE·Filed 2006·Application pending·0 cites
- 4139US2015366856A1Compounds and methods for modulating fxrTULLY DAVID C·Filed 2015·Application pending·0 cites
- 4238US10351576B2Fused tricyclic pyrazole derivatives useful for farnesoid X receptorsNOVARTIS AG·Filed 2016·Granted Jul 16, 2019·0 cites·18 claims
- 4338US2014039007A1Compositions and methods for modulating farnesoid x receptorsTULLY DAVID C·Filed 2011·Application pending·0 cites
- 4438US2012208882A1Organic CompoundsDANAHAY HENRY LUKE·Filed 2012·Application pending·0 cites
- 4536US2013261108A1Compositions and methods for modulating farnesoid x receptorsTULLY DAVID C·Filed 2011·Application pending·0 cites
- 4635US2012077854A1Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)PETRASSI HANK MICHAEL JAMES·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →